相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Estimations of the increasing prevalence and plateau prevalence of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy
Xuelin Huang et al.
CANCER (2012)
Accurate identification of A-to-I RNA editing in human by transcriptome sequencing
Jae Hoon Bahn et al.
GENOME RESEARCH (2012)
Comprehensive analysis of RNA-Seq data reveals extensive RNA editing in a human transcriptome
Zhiyu Peng et al.
NATURE BIOTECHNOLOGY (2012)
Accurate identification of human Alu and non-Alu RNA editing sites
Gokul Ramaswami et al.
NATURE METHODS (2012)
A-to-I RNA editing: The ADAR side of human cancer
Federica Galeano et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2012)
Abnormal expression of ADAR1 isoforms in Chinese pediatric acute leukemias
Cui-Hua Ma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
RNA Editing Catalyzed by ADAR1 and Its Function in Mammalian Cells
Qingde Wang
BIOCHEMISTRY-MOSCOW (2011)
Stem cell gene expression programs influence clinical outcome in human leukemia
Kolja Eppert et al.
NATURE MEDICINE (2011)
Dynamic niches in the origination and differentiation of haematopoietic stem cells
Leo D. Wang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age
Wendy W. Pang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
DARNED: a DAtabase of RNa EDiting in humans
Anmol Kiran et al.
BIOINFORMATICS (2010)
The RNA Editor Gene ADAR1 is Induced in Myoblasts by Inflammatory Ligands and Buffers Stress Response
Micah Meltzer et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2010)
Chronic myeloid leukemia: mechanisms of blastic transformation
Danilo Perrotti et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Alu Sequences in Undifferentiated Human Embryonic Stem Cells Display High Levels of A-to-I RNA Editing
Sivan Osenberg et al.
PLOS ONE (2010)
ADARs have effects beyond RNA editing
Bret S. E. Heale et al.
CELL CYCLE (2009)
Editing independent effects of ADARs on the miRNA/siRNA pathways
Bret S. E. Heale et al.
EMBO JOURNAL (2009)
Involvement of PU.1 in mouse adar-1 gene transcription induced by high-dose esiRNA
Tongde Wu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2009)
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
Sohrab P. Shah et al.
NATURE (2009)
IFNα activates dormant haematopoietic stem cells in vivo
Marieke A. G. Essers et al.
NATURE (2009)
ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling
Jochen C. Hartner et al.
NATURE IMMUNOLOGY (2009)
ADAR1 is required for hematopoietic progenitor cell survival via RNA editing
Richard XuFeng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Glycogen synthase kinase 3β missplicing contributes to leukemia stem cell generation
Annelie E. Abrahamsson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Down-regulation of RNA editing in pediatric astrocytomas - ADAR2 editing activity inhibits cell migration and proliferation
Caterina Cenci et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Miscreant myeloproliferative disorder stem cells
C. H. M. Jamieson et al.
LEUKEMIA (2008)
Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation
Stuart M. Chambers et al.
PLOS BIOLOGY (2007)
Nilotinib exerts equipotent antiproliferative effects to imatinib and does not induce apoptosis in CD34+ CML cells
Heather G. Jorgensen et al.
BLOOD (2007)
From mRNA metabolism to cancer therapy: Chronic myelogenous leukemia shows the way
Danilo Perrotti et al.
CLINICAL CANCER RESEARCH (2007)
RNA-editing-mediated exon evolution
Galit Lev-Maor et al.
GENOME BIOLOGY (2007)
Editor meets silencer: crosstalk between RNA editing and RNA interference
Kazuko Nishikura
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction
Mhairi Copland et al.
BLOOD (2006)
Modulation of microRNA processing and expression through RNA editing by ADAR deaminases
WD Yang et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2006)
Is abundant A-to-I RNA editing primate-specific?
E Eisenberg et al.
TRENDS IN GENETICS (2005)
Widespread RNA editing of embedded Alu elements in the human transcriptome
DDY Kim et al.
GENOME RESEARCH (2004)
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
CHM Jamieson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Systematic identification of abundant A-to-I editing sites in the human transcriptome
EY Levanon et al.
NATURE BIOTECHNOLOGY (2004)
Widespread A-to-I RNA editing of alu-containing mRNAs in the human transcriptome
A Athanasiadis et al.
PLOS BIOLOGY (2004)
Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia
TP Hughes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Widespread inosine-containing mRNA in lymphocytes regulated by ADAR1 in response to inflammation
JH Yang et al.
IMMUNOLOGY (2003)
Induction of protein translation by ADAR1 within living cell nuclei is not dependent on RNA editing
A Herbert et al.
MOLECULAR CELL (2002)
Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis
Q Wang et al.
SCIENCE (2000)
A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains
CX Chen et al.
RNA (2000)
分享论文
